Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (221-230 of 312) with videos related to

Pageof 32
Sort By:
The Lancet. Neurology|September 20, 2025
Research priorities for the neuronal ceroid lipofuscinosesErika F Augustine, Nadia Moore, Nicolas J Abreu, et al.
Archives of Neurology|July 16, 2002
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year periodRobert S Wilson, Julie A Schneider, Lisa L Barnes, et al.
Neurology|December 2, 2022
Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental DisabilityRebecca H Shields, Aaron Kaat, Stephanie M Sansone, et al.
Pediatrics|August 18, 2017
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current TreatmentWalter E Kaufmann, Sharon A Kidd, Howard F Andrews, et al.
Molecular Genetics and Metabolism|July 30, 2023
Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1Niamh X Cawley, Spencer Giddens, Nicole M Farhat, et al.
Journal of Neurodevelopmental Disorders|November 6, 2021
Parent-reported measure of repetitive behavior in Phelan-McDermid syndromeSiddharth Srivastava, Emma Condy, Erin Carmody, et al.
Journal of Neurodevelopmental Disorders|February 3, 2015
Emerging topics in FXTASDeborah A Hall, Rachael C Birch, Mathieu Anheim, et al.
Journal of Child Neurology|June 17, 2025
Convergent Validity of the Fine Motor, Speech, and Cognitive Domains of the 5-Domain Niemann-Pick Disease Type C Clinical Severity ScaleCristan Farmer, Monica Lewis, Nicole Farhat, et al.
Science Translational Medicine|January 15, 2016
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trialsElizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Pageof 32

Showing results (221-230 of 312) with videos related to

Sort By:
Pageof 32
The Lancet. Neurology|September 20, 2025
Research priorities for the neuronal ceroid lipofuscinosesErika F Augustine, Nadia Moore, Nicolas J Abreu, et al.
Archives of Neurology|July 16, 2002
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year periodRobert S Wilson, Julie A Schneider, Lisa L Barnes, et al.
Neurology|December 2, 2022
Sensitivity of the NIH Toolbox to Detect Cognitive Change in Individuals With Intellectual and Developmental DisabilityRebecca H Shields, Aaron Kaat, Stephanie M Sansone, et al.
Pediatrics|August 18, 2017
Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current TreatmentWalter E Kaufmann, Sharon A Kidd, Howard F Andrews, et al.
Molecular Genetics and Metabolism|July 30, 2023
Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1Niamh X Cawley, Spencer Giddens, Nicole M Farhat, et al.
Journal of Neurodevelopmental Disorders|November 6, 2021
Parent-reported measure of repetitive behavior in Phelan-McDermid syndromeSiddharth Srivastava, Emma Condy, Erin Carmody, et al.
Journal of Neurodevelopmental Disorders|February 3, 2015
Emerging topics in FXTASDeborah A Hall, Rachael C Birch, Mathieu Anheim, et al.
Journal of Child Neurology|June 17, 2025
Convergent Validity of the Fine Motor, Speech, and Cognitive Domains of the 5-Domain Niemann-Pick Disease Type C Clinical Severity ScaleCristan Farmer, Monica Lewis, Nicole Farhat, et al.
Science Translational Medicine|January 15, 2016
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trialsElizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Pageof 32